Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Peroral Endoscopic Myotomy Versus Botulinum Toxin Injection in the Treatment of Medical Refractory Spastic Esophageal Disorders

NCT02663206 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT02663206
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02663206 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Peroral Endoscopic Myotomy Versus Botulinum Toxin Injection in the Treatment of Medical Refractory Spastic Esophageal Disorders
Lead sponsor
Johns Hopkins University
Phase
Not applicable
Overall status
Withdrawn
Start date
September 30, 2016
Completion date
July 31, 2020
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

esophageal achalasia, esophageal motility disorders, esophageal spasm, diffuse